BioSig Technologies Inc CEO Kenneth Londoner tells Proactive the group has appointed Dr James Barry as an independent board director. Londoner says Dr Barry has more than 30 years of experience in the medical device industry as an executive and corporate board director.
He spent the majority of his career at Boston Scientific (NYSE:BSX) (NYSE:BSX), with increasing roles of responsibility culminating as senior vice president of corporate technology. While at Boston Scientific (NYSE:BSX) (NYSE:BSX), he led the development and launch of the TAXUS drug-eluting coronary stent that achieved annual sales exceeding $3 billion.